GSEA also demonstrated that higher BMP1 expression was associated with the gene signatures of G2M checkpoint and KRAS signaling, it may reveal that BMP1 could positively control cell cycle progression in ccRCC. Here, KRAS is linked to nonpapillary renal cell carcinoma.